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INTRODUCTION 
Enterococci are opportunistic gram-positive cocci that inhabit the 
gastrointestinal tract, the oral cavity, and the vagina in humans [1].  They can 
cause a variety of life-threatening diseases in humans including infection of the 
urinary tract, bloodstream, endocardium, abdomen, biliary tract, and burn 
wounds.  Currently Enterococci rank among the top three nosocomial bacterial 
pathogens and up to 90% of enterococcal infections in humans are caused by 
Enterococcus faecalis.  Enterococcus faecalis is known to be the most frequently 
detected species in root canals with failed endodontic treatment as well as in 
saliva and subgingival samples of periodontitis patients [2, 3].  In addition to its 
pathogenic potential, E. faecalis is also intrinsically resistant to many commonly 
used antimicrobial agents including aminoglycosides, aztreonam, 
cephalosporins, clindamycin, the semi-synthetic penicillins nafcillin and oxacillin, 
and trimethoprim-sulfamethoxazole [4]; it also frequently exhibits resistance 
mediated by genes acquired via horizontal gene transfer, mainly conjugation [5-
7].  This poses a great threat in hospital settings, particularly to patients with 
long-term hospitalization requiring use of a variety of antibiotics. 
Enterococcus faecalis contains mobile genetic elements that can rapidly 
spread antibiotic resistance and virulence genes through its population by 
conjugation [8].  Several virulence and antibiotic resistance traits can accumulate 
on a single plasmid, which can transfer and disseminate through populations.  In 
many cases, plasmid transfer is mediated by pheromone inducible conjugation 
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systems.  Unlike canonical quorum sensing in which one cell type can both 
produce and detect a signal, pheromone-inducible conjugation involves two 
distinct cell types: donor cells which contain plasmid-encoded signal detectors 
and recipient cells that function as signal producers [9].  These pheromone 
inducible plasmids have evolved a highly specific and sensitive response to 
pheromone to allow efficient communication between cells and are tightly 
regulated in order to minimize fitness costs.  The transfer functions of pheromone 
plasmids are induced by small, 7-8 amino acid peptides, encoded by the 
chromosome of most enterococcal strains.  Each peptide is highly specific for a 
cognate plasmid.  The best-studied pheromone inducible plasmids are pCF10, 
pPD1, pAD1, and pAM373, with corresponding sex pheromones cCF10, cPD1, 
cAD1, and cAM373, respectively [10, 11].  These plasmids are often found in 
clinical isolates, and up to three different pheromone responding plasmids have 
been identified in a single isolate [12].     
Extensive research has been done to understand the mechanism of 
pheromone-inducible conjugation.  An overview of the pheromone-induced 
conjugative plasmid transfer of pCF10 will be presented here and the details will 
be described later; the other E. faecalis pheromone responsive plasmids encode 
similar regulatory gene orthologs, which are described in [7, 8].  The 
chromosomal ccfA gene encodes a predicted secreted lipoprotein whose signal 
peptide is processed to the heptapeptide pheromone cCF10 by a membrane 
protease Eep (Figure 1)[13].  Mature pheromone is then released into the culture 
medium where it can be imported by a donor cell through the pCF10-encoded  
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Figure 1.  Transfer of Enterococcus faecalis plasmid pCF10.  The signal 
peptide portion of the chromosomally encoded ccfA gene product contains a 
heptapeptide pheromone cCF10 which processed from the full length polypeptide 
by Signal Peptidase II and a membrane protease Eep (upper right).  Mature 
pheromone is released into culture medium where it gets imported by a donor 
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cell through a pheromone binding protein PrgZ (upper left).  Once cCF10 gets in 
the donor cell, it then binds to and impedes the function of the negative regulator 
PrgX (lower left).  This allows transcription of aggregation substance Asc10 
which allows the two cells to stick together, enabling subsequent formation of a 
mating channel, and conjugative transfer of pCF10 (lower diagram). 
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pheromone binding protein PrgZ.  PrgZ acts in concert with the chromosomally 
encoded oligopeptide permease system (Opp) to import the pheromone into the 
donor cell.  Once cCF10 gets in the donor cell, it then binds to and alters the 
structure of the negative regulator PrgX [13].  This allows transcription of 
aggregation substance Asc10 and other conjugation proteins, which allows the 
two cells to stick together, form a mating channel, and conjugation occurs [14].   
Each of the pheromones appear to be derived from the C-terminal 
segment of the signal sequences of predicted lipoprotein genes encoded in the 
chromosome of all E. faecalis [15].  Bioinformatics analysis of E. faecalis V583 
genome sequence reveals greater than 50 putative lipoproteins with predicted 
signal sequences that may be associated with the E. faecalis membrane [16].  
The best-studied pheromone precursors and processed peptides are listed in 
Table 1.  The mature pheromone peptides for each plasmid system are very 
similar in length and are very hydrophobic, despite the specificity of each 
plasmid’s response to its cognate pheromone.  Proteolytic processing of the 
pheromone precursors must occur for the release of the mature pheromone into 
the culture supernatant (Figure 2).  Interestingly, all of the precursors have a 
conserved cysteine residue downstream of the sequence where signal peptidase 
II cleaves, releasing the signal peptide from the lipoprotein [15].  In the case of 
cCF10, the LVTLVFV pheromone sequence is three residues upstream of this 
processing site and therefore requires further processing by a host exoprotease.  
A putative membrane protease Eep has been shown to mediate endoproteolytic 
cleavage at the upstream processing site, liberate the pheromone peptide from 
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Plasmid Pheromone/precursor Precursor gene name and 
amino acid length 
pCF10 …MAGLVTLVFVLSACG… ccfA, 275 
pPD1 …GLLFLVMFLSGCV… cpd, 234 
pAD1 …AIALFSLVLAGCG… cad, 309 
pAM373 …LLGAIFILASCG… cam, 166 
Table 1.  Proteolytic processing of the pheromone precursors.  Underlined 
letters represent amino acids in the mature peptides.  Bold C indicates cysteine 
residues upstream of predicted signal peptidase II cleavage site. 
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Figure 2.  Proteolytic processing of cCF10.  Lipoprotein CcfA produced in the 
cytoplasm is exported out through the secretory apparatus.  A signal peptidase 2 
cleaves the N-terminal overhang from the conserved cysteine, then Eep, a 
membrane-embedded zinc metalloprotease further cleaves the N-terminal 
overhang to produce pheromones.  Exopeptidase cleaves several residues at the 
C-terminus to produce the mature pheromone.  PptAB, the peptide transporter 
AB, actively transports mature pheromones outside the cell. 
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its cognate lipoprotein signal sequence [9].  Eep is a predicted metalloprotease 
that has been shown to be involved in production of cCF10, cPD1, and cAD1.  A 
peptide pheromone transporter (PptAB), an ABC transporter, has been shown to 
actively transport the mature pheromones out of the cell [17].    
The most unique phenotype of pCF10-containing cells when exposed to 
exogenous cCF10 is visible aggregation of cell culture that results from 
upregulation of the expression of aggregation substance Asc10 from the pCF10-
encoded prgB gene [18].  Aggregation substance mediates close contact 
between donor and recipient cells, facilities mating pair formation in liquid 
cultures and allows efficient transfer of the plasmid.  This clumping response 
serves as a useful phenotype in quantifying pheromone activity using microtiter 
dilution assay (clumping assay) [19].   Asc10 has been shown to increase 
internalization and intracellular survival in polymorphonuclear leukocytes, adhere 
to several extracellular matrix proteins and has been shown to increase virulence 
of E. faecalis in several rabbit endocarditis models [20].   Studies by Sartingen et 
al have demonstrated that aggregation substance increases adherence and 
internalization of E. faecalis through different intestinal epithelial cells in vitro [21], 
suggesting that these aggregation substances may be involved in the 
translocation of E. faecalis through the intestinal epithelia, resulting in systemic 
infection [22]. 
Once pCF10 is transferred into a new host strain, this recipient cell 
becomes a potential donor and the related pheromone is no longer detectable in 
culture supernatants.  Since ccfA is encoded in the chromosome of all E. faecalis 
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strains, pCF10 containing cells can potentially continue to secrete pheromone 
after they have acquired the plasmid, thus there must be a mechanism to shut 
down induction by endogenously produced pheromone in these cells.  Two 
different pCF10 encoded gene products have been identified through genetic 
studies to prevent donor cells from self-induction of transfer genes by their 
endogenously produced pheromone [8].  One gene, prgQ, encodes a 
hetapeptide iCF10 (AITLIFI) that gets secreted into the extracellular medium to 
neutralize the cCF10 secreted from the same cell and competes with the 
pheromone for binding to the surface protein PrgZ [23], and to PrgX.  However, 
this is not sufficient to completely block the spontaneous self-induction in donor 
cells.  In addition to iCF10, a membrane protein PrgY has been identified that 
appears to sequester or degrade the endogenous pheromone in pCF10 
containing cells (Figure 3) [9].  The balance of cCF10 and iCF10 is carefully 
regulated such that the level of iCF10 produced is just sufficient to neutralize 
endogenous cCF10 in donor cells. The balance between cCF10 and iCF10 can 
overcome by addition of exogenous cCF10 at less than 5 molecules/responder 
cell [24].     
Previous genetic experiments and sequence analysis done in our lab 
indicated that the likely functional domains of the protein correspond to the N-
terminal region of PrgY, which is predicted by sequence analysis and functional 
studies to be on the outside of the cell membrane [9]. The N-terminal region is 
responsible for recognition of the pheromone, while the C-terminus anchors PrgY 
to the membrane via four predicted transmembrane domains [8, 9, 14] (Figure 4).   
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Figure 3. Control of self-induction of conjugation by the plasmid-encoded 
protein PrgY. Because recipient cells can potentially continue to secrete 
pheromone after acquiring the plasmid, thus there must be a mechanism to shut 
down self-induction of donor cells by endogenously produced pheromone. The 
plasmid encodes a membrane protein called PrgY that apparently plays a role in 
preventing donor cell from self-induction.  PrgY only affects endogenously 
produced pheromone and not pheromone added exogenously or from recipient 
cells. 
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Figure 4.  Structure and characterization of PrgY.  Previous experiments and 
sequence analysis done in our lab indicated that the likely topology of the protein 
includes an extracellular N-terminal domain and a C-terminal membrane 
anchoring domain. The functional N-terminal domain was identified through 
random mutagenesis and later confirmed with site-directed mutagenesis.  Most 
of the prgY point mutations that failed to reduce endogenous pheromone activity 
(red triangles) are located at the N-terminus of PrgY.  These mutations map to 
conserved residues in many species including gram-negative and gram-positive 
bacteria, archaea, plants, and mammals. Furthermore, our lab has shown that 
residues 123 to 241 of PrgY are required for specific regulation of cCF10. 
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The N-terminal functional domain was identified through random mutagenesis in 
which prgY mutations were screened and those that failed to prevent self-
induction were further confirmed with site-directed mutagenesis.  These 
mutations in prgY that abolished control of endogenous pheromone in donor 
strains mapped to conserved residues in many species including gram-negative 
and gram-positive bacteria, archaea, plants, and mammals.  Two of the random 
mutations (E45L and R50Q) mapped to residues that are conserved throughout 
the entire PrgY family [14].  Furthermore, our lab has generated chimeric pPD1 
TraB/PrgY proteins to identify segments of the PrgY N-terminal domain that 
confers specificity for cCF10.  Amino residues 125 to 241 of PrgY are required 
for specific regulation of cCF10 in vivo [9].  PrgY recognizes the mature cCF10 
peptide sequence, after processing by Eep, rather than the N-terminal sequence 
residues.  However, Eep is not required for PrgY to function.  Additionally, it was 
previously identified that the fourth residue (L4) in cCF10 peptide is important for 
PrgY recognition and that an L4I peptide variant of cCF10 abolished PrgY ability 
to reduce pheromone activity in donor cells [9].  Previous experiments have 
shown a significant amount of pheromone lingering in the cell wall [8].  In fact, 
titrations of active cCF10 in supernatant and cell fraction revealed more than 
twice as much of pheromone in the cell wall compared to pheromone in 
supernatant.  PrgY was found previously to reduce endogenous pheromone 
activity in the cell wall strain OG1RF while not affecting supernatant pheromone 
activity [8].  Based on these findings, we hypothesized that PrgY reduces 
endogenous pheromone production in donor cells by specifically binding and 
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likely degrading cCF10 as it is secreted across the cytoplasmic membrane 
(Figure 5).  The lipoprotein CcfA produced in the cytoplasm is exported out 
through the secretory apparatus (Sec) as the signal peptide gets processed by 
signal peptidase II in the membrane.  Next, the membrane protease Eep 
recognizes specifically the N-terminal domain of the cleaved signal peptide in the 
membrane and processes it further to enable the release of mature cCF10 
through a peptide pheromone transporter (PptAB), an ABC transporter [17].   
Previous genetic experiments done in our lab indicated that Eep functions 
through the recognition of the peptide sequence N-terminal to the pheromone [9].  
Chimeric fusions of the prgQ promoter with N-terminal peptide sequence derived 
from the iCF10 or cAM373 pre-processed sequence and a pheromone at the C-
terminal end were generated and assayed for the relative amounts of pheromone 
produced by each construct.  Eep was previously demonstrated to not be 
involved in production of cAM373 [25].  Pheromone production from cAM373 
signal peptide construct was the same for both Eep+ and Eep deficient strains, 
indicating that pheromone from the construct containing cAM373-dervided N-
terminal peptide is Eep independent, while the cCF10-derived N-terminal peptide 
was enhanced by Eep, indicating that the N-terminal peptide is important for 
recognition by Eep [9].  PrgY anchors in the cell membrane, probably in close 
proximity to Eep and in a precise orientation, such that it readily captures mature 
cCF10 immediately upon release from the membrane and before reimport by 
PrgZ.  It is unclear whether this inhibition occurs through degradation, 
modification, or simply blocking the release of mature cCF10 from the cell surface. 
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Figure 5.  Model #1 of endogenous pheromone control by the pCF10 
encoded protein PrgY.  The membrane protease Eep recognizes N-terminal 
domain of signal peptide and processes it to enable release of mature cCF10.  
PrgY anchors in the membrane, probably in close proximity to Eep, and specially 
targets cCF10 through amino acids 125-241 in PrgY and reduces cCF10 activity 
through an N-terminal domain.  It is unclear whether this inhibition occurs through 
degradation, modifying, or simply blocking the mature cCF10 from being 
released into the extracellular medium.     
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PrgY-like proteins are found in all biological kingdoms. No functions were 
previously known for PrgY-like proteins when I began my research project and 
the mechanism by which PrgY controls endogenous pheromone had not been 
elucidated.  PrgY is a membrane protein and due to the hydrophobicity of 
membrane proteins, biochemical and structural studies of PrgY have been 
difficult, and thus very little is known about the biochemical mechanism of PrgY.  
For this reason, it is crucial to further investigate the roles of PrgY in this 
pheromone inducible conjugation system because whatever its biochemical 
mechanism is, it clearly appears to be important to all biological kingdoms. 
Our long term goal has been to understand the control of pheromone 
activity in donor and recipient cells as well as the molecular mechanism of 
pheromone response in Enterococcus feacalis.  The first objective of my 
research was to express the cloned prgY gene and mutant derivatives, and 
develop a method to purify membrane protein PrgY and variants, with adequate 
yields and stability in solution.  My second objective was to characterize the 
biochemical activity of PrgY using the purified PrgY and variants.  To test the 
working model, affinity chromatography and Surface Plasmon Resonance were 
used to demonstrate the direct interaction between PrgY and cCF10 and their 
binding affinities.  During the course of these studies, another hypotheses was 
also developed and tested.  We hypothesized that PrgY reduces endogenous 
pheromone production in donor cells by specifically binding to cCF10 as it is 
secreted across the cytoplasmic membrane and delivering it to one or more host 
proteins that degrade or modify the pheromone.  To further investigate this, 
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purified His tag PrgY protein was used as the “bait” to capture and ‘pull down’ a 
protein-binding partner, the “prey” from OG1RF lysate that binds to PrgY and 
used mass spectrometry to identify the identity of the prey protein.  Crosslinking 
assays were also performed in an attempt to capture PrgY interacting partner in 
vivo; unfortunately, these experiments were not informative in elucidating the 
functional mechanism of PrgY.  Comparative modeling of PrgY was also carried 
out with Phyre2 and analyzed with PyMOL.  Mass spectrometry was used to 
identify possible degradation products of cCF10 in culture supernatants by 
comparing supernatants from a strain expressing PrgY to a strain lacking PrgY.  
The cumulative results of this research provide important insights into the 
molecular mechanism of PrgY.  These findings give us a better understanding of 
a new biological function, as well as providing useful information about signaling 
peptide degradation and modification in enterococci.  Furthermore, results from 
this work could also advance our understanding on the function of each of the 
PrgY family members found in a diverse range of species.   
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MATERIALS AND METHODS 
Bacterial Strains 
 Strain JRC 105 (OG1RF ΔgelE-sprE) was previously made by allelic 
exchange using conjugative delivery and the ΔgelE-sprE allele was confirmed by 
plating on THB + 3% gelatin and observed the absence of the characteristic halo 
around isolated colonies denoting gelatinase activity [9].  E. coli strain DH5𝛼 was 
used to clone and purify full length PrgY, the N-terminal portion of PrgY 
containing residues 1-241 (N-Y), and variants for biochemical studies and 
polyclonal antibody production.    
Culture Conditions 
Enterococcus faecalis was grown at 37oC in Todd-Hewitt broth (THB; 
Difco), in M9-YE glucose medium [26], a semi-defined M9-based medium 
supplemented with 0.3% yeast extract, 1% casimino acids, 0.1% glucose, 1mM 
MgSO4, and 0.1 mM CaCl2, or in chemically defined medium (Ref).  Antibiotics 
were used where appropriate at the following concentrations: tetracycline (tet) 10 
ug/ml, spectinomycin (spect) 1000 ug/ml, rifampicin (rif) 200 ug/ml, erythromycin 
(erm) 10 ug/ml, kanamycin (kan) 100ul/ml.  Nisin (Sigma) was used at 25 ng/ml 
in broth culture.  Escherichia coli DH5α was grown in Luria-Bertani (LB) broth at 
37oC, shaking, for cloning purposes with the following antibiotics: erm 200 ug/ml, 
kan 50 ug/ml, spect 50 ug/ml.    
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Plasmids 
A PrgY expression construct for E. faecalis was previously made by fusing 
the prgY gene in-frame with the first 3 codons of nisA gene in the nisin inducible 
promoter of the pMSP3545S expression vector [14].  The PCR amplified prgY 
gene from pCF10 with primer-encoded NcoI and XbaI restriction sites was cloned 
into the NcoI/XbaI sites of pMSP3545.  Furthermore, prgY gene was previously 
PCR amplified to incorporate random mutations, cloned into pMSP3545S and 
screened for nonfunctional PrgY.  The nonfunctional PrgY variants were 
identified on plate by their dry-colony phenotype that corresponds to clumping in 
broth culture.  Plasmids pMSP3545S containing wildtype prgY as well as point 
mutations R50Q and L142P were isolated, PCR amplified, and digested with 
Ncol and Xhol.  The amplicons were cloned into pET28b (Novagen, USA), an 
IPTG-inducible expression vector featuring 6-His Tag at the C-terminus for 
protein purification.  The resulting plasmids were transformed into E.coli DH5α for 
protein expression and purification.  
DNA Manipulation and Cloning 
Plasmids were isolated with Qiagen mini kit (Qiagen), digested DNA 
products were purified with Qiaquick gel extraction kit (Qiagen), and PCR 
products were purified with Qiaquick PCR purification kit (Qiagen).  Plasmid 
constructs were verified with DNA sequencing by SimpleSeq (Eurofins).  
Restriction enzymes were purchased from Promega and New England BioLabs.  
PCR was performed with a Techne TC-412 Thermal Cycler. 
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Determination of Pheromone Activity 
Pheromone induction can be detected by the formation of visible clumps in 
donor cell cultures exposed to the peptide [26]; this phenotype served as the 
basis for the Microtiter Assay (Clumping Assay) used to determine pheromone 
activity.  One hundred microliters of either E. faecalis OG1RF culture 
supernatant, eluted fractions from binding assays, or synthetic pheromone was 
added to the first well of a microtiter plate, and twofold serial dilutions were made 
across a row of wells. Then 10 μl of an overnight culture of E. faecalis 
OGIRF(pCF10) was added to each well, and the plate was incubated at 37°C 
with shaking for 2 hours.  Pheromone activity was reported as the titer, which is 
the reciprocal of the highest twofold dilution showing a positive clumping results.        
Proteins Expression and Purification 
An overnight culture of Escherichia coli DH5a expressing a desired protein 
was grown in Luria-Bertani (LB) broth at 37oC with kan 50 ug/ml, then diluted into 
1 L of LB medium with kan 50 ug/ml, incubated at 37oC shaking for about 3 
hours.  At exponential phase, culture was induced with 1 mM IPTG final 
concentration and continue to incubate at 37oC shaking for another 1 hour.  Cells 
were collected by centrifugation and treated with lysozyme solution (0.5 mg/L) in 
1X Bind buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris HCl) with 20% 
glycerol for 15 minutes at 37oC.  Cells were sonicated on ice and centrifuged at 
45,000 rpm for 45 minutes at 4 oC.  Pellets were collected and resuspended in 1x 
Bind buffer with 6 M guanidine HCl and incubated on ice for 1 hour, then 
centrifuged at 38,000 rpm for 40 minutes and the supernatant (membrane 
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fraction with protein of interest) was collected.  Ni-NTA agarose (ThermoFisher 
Scientific) and a purification column were used to purify His-tagged proteins.  
Columns were prepared with 1.5 mL of Ni-NTA agarose, charged with 7.5 ml of 
1X Charge buffer (50 mM NiSO4), washed with water, and then saturated the 
column with 1X Binding buffer with 6M guanidine HCl.  Membrane fractions with 
protein of interest were added to the column and allowed to bind at 4 oC for 1 
hour.  Columns were then washed with 1X Wash buffer (60 mM imidazole, 500 
mM NaCl, 20 mM Tris HCl) with 6 M guanidine HCl, then with gradually reduced 
guanidine HCl concentrations with a final wash containing only 1X Wash buffer 
without guanidine HCl.  Samples were eluted with 1X Elution buffer (1 M 
imidazole, 500 mM NaCl, 20 mM Tris HCl) into several fractions.   
For anti-PrgY polyclonal antibody production, protein was purified as 
described above, except 1% of n-Dodecyl B-D-Maltoside detergent was used to 
solubilize proteins instead of 6M guanidine HCl.   
Production of PrgY Polyclonal Antibody 
A pre-immune bleed (5 mL) was collected on Day 0 as control serum.  On 
Day 1, about 0.25 ml (0.5 mg) of purified full length PrgY was injected into a 
rabbit subcutaneously.  On Day 14, a booster injection of 0.25 mg of purified 
PrgY was administered subcutaneously.  On Day 28, a second booster injection 
of 0.25 mg of purified PrgY was administered subcutaneously.   Day 35, 5 mL of 
serum was collected and assayed by Western blotting.  On Day 42, a third 
booster of 0.25 mg of purified PrgY was administered subcutaneously.  On Day 
56, 50 mL of serum was collected.  The antibody was absorbed with 100x 
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volume of OG1RF cell extract overnight at 4oC and assayed with Western blot at 
an antibody concentration of 1:10,000.      
Protein Binding Assays 
 Pull-down Assay: Recombinant cellular lysates were prepared by 
sonication and lysozyme lysis (see Protein Expression and Purification).  The cell 
membrane fraction was recovered by high-speed centrifugation.  This mixture 
was incubated with 3 mL of Nickel Sepharose (ThermoFisher Scientific) and then 
washed with phosphate buffer to remove non-specific proteins.  Then synthetic 
cCF10 or a peptide variant was added to the column to allow binding to N-Y for 1 
hour at 4oC.  The unbound flow thru fractions were collected and cCF10 activity 
was detected by microtiter clumping assays.   
Surface Plasmon Resonance (SPR): These assays were carried out in 
collaboration with Dr. Albert Tai of Tufts University.  The purified His tag N-Y was 
captured in the NTA chip (GE Life Sciences) using a Biacore T100 (GE Life 
Sciences).  For each cycle, a 2 mM Ni2+ solution was first injected onto flow cell, 
followed by the injection of N-Y onto the flow cell for capturing.  Once the 
capturing was completed, the peptide was injected across both the reference 
flow cell and experimental flow cell for 4 minutes.  Once the injection was done, 
the system was allowed to dissociate for 15 minutes, during which the bound 
peptide will start to dissociate.  At the end, there are regeneration cycles to 
remove all Ni2+/protein/peptide from the surface prior to the next binding cycle.  
For each cycle, one concentration of peptide is tested, and each concentration is 
tested twice.  The range of peptide tested in this experiment was 0.9 nM – 630 
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nM.  Binding signals were corrected for non-specific binding by subtracting the 
signal from the control flow cell using Biacore T100 Evaluation Software version 
1.1 (http://www.biacore.com).  The affinities between N-Y and peptides were 
calculated by using the 1:1 Langmuir binding model.  The fit analysis of the 
model to the date was determined by χ2 value, which is the square of the 
differences between the theoretical ideal curve to the actual curve, calculated 
according to this equation:  
Χ2  =  Σ(rf  −  rx)2/(n  −  p) 
where rf is the fitted value at a given point, rx is the experimental value at that 
point, n is the number of data points, and p is the number of fitted parameters.    
Pheromone Activity in the Presence or Absence of PrgY 
A microtiter assay was used to detect effects of purified N-Y protein on 
pheromone activity. A 96 well plate was filled with M9-YE medium.  A 1:2 serial 
dilutions of synthetic cCF10 was made across a 96 well plate, starting with 2 ul of 
50 ng/ml cCF10.  Purified N-Y or PrgY derivatives containing amino acid 
substitutions were added to appropriate rows and incubated for one hour at 
37oC.  Responder cells were added and incubated for 2-4 hours.  Relative 
pheromone induction was detected by the formation of visible clumps in donor 
cell cultures exposed to the synthetic cCF10 peptide in the presence or absence 
of purified N-Y.   
SDS-PAGE and Western Blot Analyses 
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Cell cultures were grown overnight (14 hrs) in THB or M9-YE at 37oC, 
diluted into fresh THB with 25 ng/ml nisin, then grown for 2.5 - 3hr (1.2 - 1.5 
O.D.).  Cells were collected by centrifugation and treat with lysozyme solution or 
mutanolysin (10 mg/ml lysozyme and/or 250 U/ml mutanolysin, 10 mM Tris-HCl 
(pH 8.0), 50 mM NaCl, 10 mM EDTA) at 37oC for 15 minutes.     
Crosslinking Assays 
OG1RF pMSP3545 YSN overnight culture was prepared in M9-YE or THB 
with 10 ug/mL Erm at 37oC, diluted into fresh M9-YE or THB with 25 ng/mL nisin 
and grown for 3 hr at 37oC.  Cells were collected by centrifugation and washed 
with 100 ul of PBS buffer for each 100ul of cell culture.  Cells were resuspended 
with 100 ul of PBS and DSG at 0mM, 1 mM, 1.5 mM, and 2 mM.  Cells were 
incubated at room temperature for 30 minutes and 15 mM Tris was added to 
each sample and continue to incubate at room temperature for 15 minutes to 
quench the reaction.  Cells were collected by centrifugation and were 
resuspended with 50 ul of 5 mg/ml lysozyme solution for 30 minutes at 37oC.  
Cells were resuspended into SDS buffer for Western blot analysis.     
In-Gel Typsin Digest for Mass Spectrometry Analysis 
Protein bands from polyacrylamide gels were excised with a sterile razor 
blade and were cut into ~2 x 2 mm cubes.  Gel bands were washed and de-
stained (removed silver stain) with 1:1 solution of 30 mM potassium ferricyanide 
and 100 mM sodium thiosulphate made freshly before use.  Excised gel bands 
were incubate with solution for 8 minutes, then washed 4 x with 1 mL of Mill-Q 
24 
 
water.  Gels were then incubated with 75 ul 1:1 100 mM ammonium 
bicarbonate:acetonitrile for 15 min at room temperature then washed with 75 ul of 
100% acetonitrile for 30 sec – 1 min.  After pieces shrunk and turned white and 
semi-opaque, acetonitrile was removed and gels were rehydrated with 75 ul 10 
mM DTT in 50 mM ammonium bicarbonate, incubated for 1 hr at 56 °C in water 
bath.  Then DTT solution was removed and incubated with 75ul of 55 mM 
iodoacetamide in 50 mM NH4HCO3 for 30 min at room temperature in the dark 
(iodoacetamide is light sensitive).   The iodoacetamide solution was removed and 
washed with 75 ul 1:1 acetonitrile:100 mM ammonium bicarbonate and 
rehydrated in digestion buffer at 4 °C (50 mM NH4HCO3, 5 mM CaCl2, 5 ng/ul 
trypsin) on ice for 15 min. Replaced solution with 70 ul 50 mM NH4HCO3, 5 mM 
CaCl2 and incubated at 37 °C overnight in a warm-air incubator.  The 
supernatant from overnight incubation was recovered and purified with C-18 
column (Thermo Scientific) prior to submission for mass spec analysis.   
Shotgun MS analysis 
The protein sequence database was obtained from UNIPROT 
(http://www.uniprot.org).  MASCOT software (http://matrixscience.com) was used 
to match the fragmentation spectra obtained from a trypsin digested protein 
sample to a protein sequence database.  In general, the trypsin digested 
peptides are mostly between 7 and 20 amino acids long, with an average of 11 
amino acids.  Scaffold software (http://www.proteomesoftware.com) was used to 
combine the most important data produced by MS with the identification process, 
and to distribute the results in an organized table.  Results listed in the table are 
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the identified proteins, the accession number, predicted molecular weight, the 
probability, and the number of assigned spectra.  The numbers of assigned 
spectra give an idea of the confidence of the identification.  In general, a good 
identification should have at least 4 or more spectra that correspond to a 
particular protein [27].  The filtering parameter was set at 95% probability with 1 
peptide minimum.    
Computer Analysis and Structural Modeling 
 Comparative modeling of PrgY was carried out with Protein 
Homology/analogy Recognition Engine V 2.0 (Phyre2) hosted at 
http://www.sbg.bio.ic.ac.uk/phyre2/.  Comparative modeling of the human TIKI1 
active site was previously carried out by MODELLER, followed by KoBaMIN 
structural refinement [28].  Comparative modeling of PrgY active site was carried 
out with Phyre2 and analyzed with PyMOL. 
Mass Spectrometry Analysis of Culture Supernatant 
A PrgY expression construct was previously made by fusing the prgY 
gene in-frame with the first 3 codons of nisA gene in the nisin inducible promoter 
of pMSP3545S vector [14].  The plasmid pPCR4 was previously constructed to 
carry the prgQ Orf with an N-terminal peptide sequence derived from the iCF10 
pre-processed sequence and a pheromone cCF10 at the C-terminal end.  A cell 
culture was grown overnight (14 hrs) in M9-YE at 37oC.  Cells were collected by 
centrifugation and were washed 3x with fresh M9-YE.  Cells were then diluted 
into fresh M9-YE to an O.D. = 0.1 and grown for about 2 hr.  At an O.D. = 0.3, 
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culture was induced with 25 ng/ml nisin and incubated for about 3 hr.  At an O.D. 
= 1.2, cells were spun down by centrifugation and supernatant was collected for 
mass spectrometry analysis.   
The culture supernatant was purified with C-18 column (C-18 Hypersep 
Thermo Scientific).  Then sample was acidified with Trifluoroacetic acid (TFA) to 
bring the pH to 2.  About 20 ml of culture supernatant was added to the C-18 
column.  Column was washed with 3ml of HPLC water with 0.1% TFA, then 
washed with 3 ml of HPLC water with 0.1 % TFA and 20% acetonitrile (ACN), 
and finally eluted with 1.5 ml of HPLC water with 0.1% TFA with 80% ACN.  
Eluted fraction was placed in a SpeedVac to evaporate ACN.  The sample was 
then resuspended with 20 ul of HPLC water and 2ul was loaded to QTRAP 5500 
to analyze the sample.        
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RESULTS 
I. Purification and binding between PrgY and cCF10 
 
Expression and purification of PrgY and variants 
In order to understand the mechanism of PrgY and to demonstrate the 
direct interaction between PrgY and its cognate peptide cCF10, it was imperative 
to purify the protein.  A PrgY expression construct was previously made by fusing 
prgY gene in-frame with the first 3 codons of nisA gene in the nisin inducible 
promoter of pMSP3545S vector [14].  Furthermore, prgY gene was previously 
PCR amplified to incorporate random mutations, cloned into pMSP3545S and 
screened for nonfunctional PrgY.  The nonfunctional PrgY variants were 
identified on plate by their dry-colony phenotype that corresponds to clumping in 
broth culture.  This screen resulted in eight point mutations and two truncation 
mutations that failed to reduce endogenous pheromone activity and resulted in 
clumping phenotype (Figure 4) [14].  Six of the eight point mutations were located 
on the N-terminal portion of PrgY, which is predicted to lie outside the 
membrane.  Additionally, our lab has generated chimeric pPD1 TraB/PrgY 
proteins to identify region of the PrgY domain that confers specificity for cCF10.  
Amino residues 125 to 241 of PrgY, which are predicted to lie outside the 
membrane, are required for specific regulation of cCF10 in vivo [9].  Arginine 50 
is a conserved residue throughout the entire PrgY family, and L142P is in the 
specificity region that was previously identified to be important for interacting with 
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the pheromone.  Of the eight point mutations, the PrgY alleles encoding two 
amino acid variants, R50Q and L142P, were selected for cloning and protein 
purification.       
Membrane proteins are often very difficult to purify because they are 
embedded in the lipid bilayer and require detergents to become soluble in 
aqueous solution.  Since prgY mutations affecting endogenous pheromone 
control were located primarily in the N-terminal region of PrgY, we initially 
expressed and purified the N-terminal portion of PrgY (N-Y) containing residues 
1-241.  Plasmids pMSP3545S containing wild type prgY or the R50Q and L142P 
variant alleles were isolated, PCR amplified, and digested with Ncol and Xhol, 
and the amplicons were cloned into pET28b (Novagen, USA), an IPTG-inducible 
expression vector featuring a His Tag at the C-terminus for protein purification 
(see materials and methods).  Cells were sonicated on ice to break down cellular 
membranes and fragmentation of DNA until the sample was no longer viscous 
otherwise the extract would be so viscous that it would clog the purification 
column.  Unfortunately, N-Y and variants were all found in the insoluble fractions, 
suggesting inclusion bodies were formed.  Changes in IPTG concentrations and 
induction times were tested but inclusion bodies still formed.  Lowering the 
incubation temperature to 30 oC during IPTG induction resulted in fewer inclusion 
bodies and solubilized about 30% of the recombinant protein.  The remaining 
inclusion bodies were solubilized with 6M guanidine HCl (see materials and 
methods).  Ni-NTA agarose (Thermo Fisher Scientific) and purification column 
was used to purified His-tagged proteins.  Early preparations resulted in very low 
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yields with some low molecular weight contaminants.  We initially thought that 
perhaps PrgY was degraded by host proteases or that PrgY was not stable at 
room temperature since the purification step was done at room temperature.  
Next, the Halt Protease Inhibitor Cocktail (ThermoFisher Scientific) was used and 
the column purification step was done at 4 oC.  This resulted in cleaner purified 
protein but still with low yield.  We refrained from using Halt Protease Inhibitor 
Cocktail in subsequent purifications because we did not want the protease 
inhibitor to interfere with the biochemical activity of PrgY.  Next, batch binding 
purification attempts were made in which His-bind resin was placed in a tube 
instead of the column.  Membrane fractions with protein of interest were added to 
tubes and allowed to bind at 4 oC for 1 hour.  Tubes were then spun down to 
separate the resin from the purified protein.  This method resulted in a higher 
yield but not very clean preparations, most likely because the resin was disturbed 
between washes when the tube was transferred in and out of the centrifuge, 
allowing contaminated resin to resuspend into the purified supernatant.  Lastly, 
membrane fraction with protein of interest was added to the column and allowed 
to bind at 4 oC for 1 hour.  The guanidine HCl concentration in wash buffers was 
gradually reduced with a final wash without guanidine HCl in order to minimized 
precipitations, and this resulted in the highest yield and the cleanest protein 
(Figure 6).  The full length PrgY protein was purified as described above, except 
1% of n-Dodecyl B-D-Maltoside detergent was used to solubilize proteins (Figure 
7).  Other detergents including Triton-X and n-Octyl-β-D-Glucopyranoside were 
tested but n-Dodecyl B-D-Maltoside gave the highest yield.  A PrgY polyclonal  
30 
 
 
Figure 6.  Purified NY and variants.  The N-terminus portion of PrgY (N-Y), 
containing residues 1-241, and variants R50Q and L142P were expressed in 
Escherichia coli DH5α, induced with 1mM IPTC final concentration, solubilized 
with 6M guanidine HCl, purified with Ni-NTA agarose (Thermo Fisher Scientific), 
and assayed with polyacrylamide gels with GelCode Blue Stain Reagent 
(ThermoFisher Scientific). 
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Figure 7. Purified full length PrgY.  PrgY was expressed in Escherichia coli 
DH5α, induced with 1mM IPTC final concentration, solubilized with purified with 
1% of n-Dodecyl B-D-Maltoside, purified with Ni-NTA agarose (ThermoFisher 
Scientific), and assayed with polyacrylamide gels with Silver Stain Reagent 
(ThermoFisher Scientific). 
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antibody was developed by immunization of rabbits with purified full length PrgY 
(see Materials and Methods).  The antibody was absorbed with OG1RF cell 
extract and assayed against OG1RF (pMSP3545S) and 
OG1RF(pMSP3545YSN) cell lysates, as control and PrgY, respectively, with 
Western blot at an antibody concentration of 1:10,000 (Figure 8).  The PrgY 
antiserum reacted with a faint nonspecific band at ~70 kDa in both control lysate 
and lysate expressing PrgY, while an intense band migrating at the expected size 
for PrgY (~45 kDa) was detected in the lysate from the strain expressing PrgY.  
Although full length PrgY purified with n-Dodecyl B-D-Maltoside worked well for 
antibody production, it was very difficult to run biological assays with this protein, 
as it precipitated out of solution once the detergent was removed though dialysis.  
The full length PrgY was partially solubilized with 6M guanidine HCl, however, 
with very low yield.   
    
N-Y specifically reduces the amount of pheromone flow-thru in pull-down assays, 
demonstrating the direct binding between cCF10 and N-Y in vitro.     
Previous work suggests that cCF10 is specifically controlled by PrgY, 
however, a direct interaction between PrgY and cCF10 has not been shown.  We 
initially used pull-down assays to demonstrate the direct and specific interaction 
between PrgY and cCF10.  Cell membrane fractions containing His-tag N-Y 
(described above) were incubated with Nickel Sepharose which was then 
washed with phosphate buffer to remove weakly bound proteins.  As a result, 
His-tag N-Y was bound to the column and allowed us to test its binding to cCF10.      
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Figure 8.  Western blot of PrgY polyclonal antibody.  The PrgY antibody was 
absorbed with 100x volume of OG1RF cell extract overnight at 4oC and assayed 
with Western blot at an antibody concentration of 1:10,000.  OG1RF 
(pMSP3545S) and OG1RF(pMSP3545YSN) cell lysates were assayed as control 
and PrgY, respectively.      
  
34 
 
Typically about 200 ug/ml of N-Y could be eluted from the Nickel column from 3 
mL of cell membrane fraction containing His-tag N-Y.  The molecular weight 
difference between N-Y and cCF10 is about 34-fold.  Assuming a 1:1 molar ratio 
of binding between N-Y and cCF10, for every 3ml of cell membrane fraction that 
was added to the nickel column, 5.9 ug/mL of cCF10 added to the column and 
the flow through fractions containing unbound cCF10 were collected.  The 
relative amounts of unbound cCF10 were detected by micro-titer assays.  The 
His-tag N-Y bound to the nickel column was then eluted to determine total N-Y 
bound to column via Nano Spec.  The cCF10 flow-thru faction from the column 
without N-Y was assayed and normalized to 100 to account for nonspecific biding 
of cCF10 to the resin (Figure 9A).  In the presence of N-Y, cCF10 in flow-thru 
fraction was significantly reduced to 0.4, indicating that most cCF10 that was 
added to the column was bound to N-Y (Figure 9A).  The fourth residue (L4) of 
the cCF10 peptide was previously identified to be important for PrgY recognition 
[9], and that an L4I peptide variant of cCF10 abolished PrgY ability to reduce 
pheromone activity in donor cells.  Similarly, when L4I was added to the column, 
fewer L4I was bound to N-Y as indicated by higher L4I in the flow-thru fraction 
(Figure 9B).  The peptide cPD1 pheromone which induces transfer of the pPD1 
plasmid [29], was previously shown to have no pheromone activity in the pCF10 
system but does interact with PrgY [14], partially blocked binding of and cCF10 to 
N-Y bound to the column, resulting in more cCF10 in flow thru fractions (Figure 
9C).  Although the absolute amount of cCF10 recovered from each column 
varied between experiments, the ratio of cCF10 recovered between N-Y bound 
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Figure 9.  Pheromone flow-thru in the pull-down assay.  Recombinant cellular 
lysates were prepared by sonication and lysozyme lysis.  Cell membrane fraction 
was recovered by high-speed centrifugation.  This mixture (contained about 200 
ug/ml of N-Y) was then incubated with Nickel Sepharose and then washed with 
phosphate buffer to remove non-specific proteins.  Either 5.9 ug/mL of synthetic 
cCF10 or a peptide variant was added to the column to allow binding to N-Y and 
the unbound flow thru fractions were collected and cCF10 activity was detected 
by microtiter clumping assays.  (A) In the absence of N-Y, cCF10 flow-thru 
faction was assayed and normalized to 100.  In the presence of N-Y, cCF10 in 
flow-thru fraction was significantly reduced, indicating that most cCF10 that was 
added to the column was bound to N-Y.  (B) The fourth residue of the cCF10 
peptide was previously shown to be important for PrgY recognition, and when L4I 
was added to the column, less L4I bound to N-Y indicated by higher L4I in the 
flow-thru fraction.  (C) With 5.9 ug/ml of competing peptide cPD1 (which has no 
pheromone activity) partially blocked binding of NY and cCF10, resulted in more 
cCF10 in flow thru fractions as indicated by higher titer.  The data shown are 
representative of at least three independent experiments.     
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columns versus control columns remained the same.  
Although the experiments described above confirmed the direct binding 
between cCF10 and N-Y in vitro, I experienced some difficulties quantify the 
binding interactions due to some non-specific binding of cCF10 to the resin.  In 
order to determine the affinities between N-Y and cCF10, Surface Plasmon 
Resonance (SPR) kinetic analysis was performed.  For this particular assay, I 
was working in collaboration with Dr. Tai, an expert in SPR, at the Biacore core 
facility at Tufts University.  Purified his tag N-Y was immobilized to the NTA 
sensorchip and increasing concentration of synthetic cCF10 was injected over 
the sensor chip (see materials and methods).  Once the injection was done, the 
bound peptides were allowed to dissociate.  Binding signals were calculated with 
BIA evaluation software as previously described [30].  The data suggests that 
cCF10 binds to N-Y slowly (low on rate), and it also falls off very slowly (slow off 
rate) (Figure 10A).  The dissociation of cCF10 from the immobilized N-Y on the 
NTA sensorchip was very slow, and had a monophasic morphology, consistent 
with a single receptor-ligand interaction.  Furthermore, the binding of cCF10 to N-
Y can be saturated at a level comparable to the calculated theoretical maximum 
(60RU) assuming 1:1 binding.  As expected, no significant binding was detected 
between cCF10 and N-Y variant R50Q since R50 is located within the functional 
domain and is a conserved residue throughout the entire PrgY family (Figure 
10B). Synthetic cCF10 variant L4I (633nM) was also injected stepwise into a flow 
cell containing NTA sensor chip with 2000RU of purified His-tagged N-Y 
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Figure 10.  Surface plasmon resonance kinetic analysis of cCF10 binding to 
N-Y.  Synthetic cCF10 (633nM) was injected stepwise into a flow cell containing 
NTA sensor chip with 2000RU of purified His-tagged N-Y (A) or N-Y mutant (B).  
The binding of cCF10 to N-Y can be saturated at a level comparable to the 
calculated theoretical maximum (60RU) assuming 1:1 binding (A).  No significant 
binding between cCF10 and N-Y variant R50Q was detected (B).  Synthetic 
peptide variant L4I (633nM) was also injected stepwise into a flow cell containing 
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NTA sensor chip with 2000RU of purified His-tagged N-Y (C) or N-Y variant 
R50Q (D).  The binding affinity of L4I to N-Y was lower than cCF10 to N-Y but 
can still be saturated at 60RU.  No significant binding between L4I and N-Y 
variant R50Q.  For comparison, synthetic cCF10 (79nM) was injected stepwise 
into a flow cell containing NTA sensor chip with purified His-tagged PrgX, which 
has a stronger binding affinity (KD ~10-13) (E).   
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ka (M-1 s-1) kd (s-1) KD (M) χ2 
cCF10/NY 6.126x106  1.637x10-4 2.672x10-11 4.41 
L4I/NY 2.000x106 1.472x10-3 7.358x10-10 1.79 
Table 2. Affinities of peptides for N-Y.  Binding affinities yielded by kinetic 
modeling using lower concentration range (0.6 nM – 10nM).  ka, association rate 
constant; kd, dissociation rate constant; KD, dissociation constant. 
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(Figure 10C) or N-Y variant R50Q (Figure 10D).  The binding affinity of L4I to N-Y 
was lower than cCF10 to N-Y (Figure 10C), which was expected since fourth 
residue of the cCF10 peptide was previously shown to be important for PrgY 
recognition [31], but could still be saturated at 60RU.  No significant binding 
between L4I and N-Y variant R50Q was detected (Figure 10D), which confirmed 
that the conserved arginine 50 was important for interacting with the pheromone.  
Binding signals were corrected for non-specific binding by subtracting the signal 
from the control flow cell.  The pCF10 encoded PrgX, which controls the initiation 
of transcription of conjugation genes, also interacts with cCF10.  Higher binding 
affinity of PrgX to cCF10 was observed compared to N-Y and cCF10 (Figure 
10E).  These observations indicate potential limitations of this in vitro assay as 
the purified PrgY lacks the transmembrane domain and consequently N-Y could 
be less able to to effectively capture cCF10 than the membrane-anchored full-
length version found in cells, while full length purified PrgX (a cytoplasmic 
protein) was used.  The Langmuir model was used to determine the kinetic 
constants of these bimolecular interactions through SPR analysis.  This model 
describes a 1:1 interaction in which one ligand molecule interacts with one 
analyte molecule as we hypothesized for PrgY and cCF10.  The dissociation 
constant (KD) of N-Y and cCF10 calculated by this model was 2.672x10-11 M, 
suggesting a strong interaction between cCF10 and N-Y (Table 2).  The binding 
curves fit well to the 1:1 Langmuir binding model (χ2 = 4.41).  The KD of N-Y and 
L4I was 7.358x10-10 M, suggesting weaker interaction between N-Y and L4I 
compare to N-Y and cCF10.  The binding curves also fit well to the 1:1 Langmuir 
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binding model (χ2 = 1.79).  These affinities yielded by kinetic modeling using 
lower concentration range (0.6 nM – 10nM).  No significant binding between N-Y 
variant R50Q and cCF10 as well as L4I and N-Y variant R50Q, thus no kinetic 
modeling was calculated for these interactions.                 
 
The amino-terminal fragment of PrgY specifically interacts with cCF10 in solution, 
but does not directly degrade or modify cCF10. 
We initially hypothesized that PrgY reduces endogenous pheromone 
production in donor cells by specifically binding and degrading cCF10 as it is 
secreted across the cytoplasmic membrane.  If this was the case then in the SPR 
experiment when synthetic cCF10 was injected over the sensor chip with 
immobilized N-Y, N-Y would have degraded cCF10 and should not give us a 
binding kinetic result.  Results from the pull-down assay and SPR provided great 
binding kinetic data between N-Y and cCF10, however, these binding results 
described above did not indicate degradation.  For this reason, we wanted to 
examine this further using microtiter assays to detect pheromone activity in the 
presence or absence of N-Y (see materials and methods).  Briefly, the purified N-
Y was either pre-incubated with cCF10 in M9-YE medium for 1 hour prior to 
adding responder cells OG1RF or was added at the same time as responder 
cells, and examined the effects of the purified N-Y protein on pheromone activity.  
We hypothesized that PrgY degrades or modifies cCF10 as it is released from 
cell membrane by PptAB after it has been processed by the protease Eep; these 
data suggested that the purified amino-terminal fragment of PrgY specifically 
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interacts with cCF10 in solution, but did not irreversibly sequester, or directly 
degrade or modify cCF10 (Table 3).  Pheromone activity was not reduced in the 
presence of purified N-Y but rather increased when N-Y was incubated with 
synthetic pheromone for 1 hr prior to adding responder cells (Table 3A).  No 
change in pheromone activity was observed if N-Y was added along with 
responder cells without pre-incubation with synthetic pheromone.  Incubation of 
N-Y with the heterologous peptide pheromone cAD1 had no effect on cAD1 
activity, indicating that the interaction between PrgY and cCF10 was specific 
(Table 3B).  Point mutations (R50Q, L142P) that failed to reduce endogenous 
pheromone activity in vivo, also reduced or eliminated the in vitro binding 
interaction (Table 3C).  Rather than detecting pheromone degradation, I found an 
apparent binding activity of N-Y for cCF10 that could potentially protect the 
pheromone from degradation by secreted enterococcal proteases in liquid 
medium (Table 3).  The addition of N-Y enhanced clumping rather than reducing 
clumping.  In the presence of N-Y, incubation of N-Y with the heterologous 
peptide pheromone cAD1 had no effect on cAD1 activity, indicating that the 
interaction between PrgY and cCF10 was specific.  The specificity of the 
interaction is also supported by the fact that point mutations that abolished the 
ability of PrgY to control endogenous pheromone in vivo, also reduced or 
eliminated the in vitro binding interaction.  The apparent increase in the titer of 
cCF10 incubated with N-Y probably resulted from N-Y protecting the soluble 
pheromone from protease digestion in the culture medium by binding to the free 
peptide (Figure 11).  Microtiter assays for cCF10 activity actually comprise a race 
between the peptide getting degraded by host protease in the culture medium  
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A 
Addition of N-Y Incubation Pre (1hr) Titer (3hr) Titer (4hr) 
+ + 256 2048 
- + 32 512 
+ - 32 1024 
- - 32 1024 
 
B 
Addition of N-Y Incubation Pre (1hr) Titer (3hr) Titer (4hr) 
+ + 8 8 
- + 8 8 
+ - 16 16 
- - 16 16 
 
C 
Addition of N-Y 
variants 
Incubation Pre (1hr) Titer (3hr) Titer (4hr) 
WT + 32 64 
R50Q + 8 16 
L142P + 8 32 
- + 8 16 
WT - 8 16 
R50Q - 8 16 
L142P - 8 16 
- - 8 16 
 
Table 3. Purified amino-terminal fragment of PrgY specifically interacts with 
cCF10 in solution, but does not directly degrade or modify cCF10.  Micro-
titer assays were used to detect pheromone activity in the presence or absence 
of purified N-Y.  The purified N-Y was either pre-incubated with cCF10 in M9 
medium 1 hour prior to adding responder cells OG1RF or was added the same 
time as responder cells.  The titer reported represent the reciprocal of the highest 
dilution that induced clumping.  (A) When N-Y was incubated with synthetic 
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pheromone for 1 hr prior to adding responder cells, pheromone activity was not 
reduced but actually increased.  (B) Incubation of NY with the heterologous 
peptide pheromone cAD1 had no effect on cAD1 activity.  (C) Point mutations 
(R50Q, L142P) that abolished the ability of PrgY to control endogenous 
pheromone in vivo, also reduced or eliminated the in vitro binding interaction. 
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and N-Y protecting the peptide long enough to allow the peptide to re-enter the 
cell, resulting in an apparent enhancement of  pheromone activity.  The high-
affinity pheromone binding protein PrgZ, expressed on the surface of the 
responder cells in the assays removed the N-Y-bound peptide, and imported it 
into the cell for induction, leading to an increase in the apparent pheromone 
activity.  These data suggest that PrgY might not directly degrade pheromone as 
we previously thought but it may have a chaperone-like activity involving 
“presentation” of the pheromone to a cell-associated protease or peptidase for 
degradation (Figure 12).  Alternatively, the C-terminal domain of PrgY may be 
important for maintaining a conformation that is needed for optimal pheromone-
degrading enzymatic activity, but not for specific binding.  In this assay, only the 
soluble purified His-tagged N-terminal fragment containing residues 1-241 was 
incubated with cCF10, and thus N-Y might not be able to maintain a 
conformation that is required for enzymatic activity. As a result, no reduction of 
pheromone activity was observed in this in vitro assay.  Initial attempts to use full 
length PrgY in this type of assay were not successful due to immediate 
precipitation of PrgY during in the incubation with peptides.  PrgY was later 
successfully purified with reasonable efficiency and stability (see materials and 
methods).  Micro-titer assays were used to detect pheromone activity in the 
presence of purified full-length PrgY, and results were very similar to those 
obtained with N-Y.  PrgY appeared to bind to but not degrade cCF10, leading to 
an increased in titer due to the protection of the soluble pheromone from 
protease digestion in the culture medium.  This reinforces the idea that the  
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Figure 11.  NY protects the soluble pheromone from host protease 
digestion in the culture medium by binding to the free peptide.  (A) In the 
absence of purified N-Y, a portion of the peptide added exogenously was 
degraded by general host proteases.  (B) N-Y was bound to the peptide but did 
not degrade the peptide and instead protected of the soluble pheromone from 
protease digestion in the culture medium.  We hypothesized that the high-affinity 
pheromone binding protein PrgZ, expressed on the surface of the responder 
cells, removed the NY/peptide complex, and imported the protected pheromone, 
leading to an increase in the apparent pheromone activity.   
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Figure 12.  Model #2 of endogenous pheromone control by the pCF10 
encoded protein PrgY.   PrgY was thought to regulate endogenous induction by 
sequestration or degradation of pheromone within the cell wall, thereby reducing 
endogenous pheromone activity in donor cells.  In vitro data suggests that PrgY 
specifically interacts with cCF10 in solution, but does not directly degrade or 
modify cCF10.  An alternative model consistent with the data is that, PrgY may 
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have a chaperone-like activity involving “presentation” of the pheromone to a cell-
associated protease or peptidase for degradation as depicted in this figure. 
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transmembrane portion of PrgY is not involved in catalytic activity.  There is a 
possibility that the transmembrane protein was not active in solution or its 
interacting partner was missing when it was purified.  Alternatively, the purified N-
Y may lack a metal ion cofactor that plays a critical role in coordinating amino 
acids in the active site of PrgY.    
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II. Examination of the mechanistic models for PrgY function  
 
Searching for a host protease that interacts with PrgY 
The binding data with purified proteins suggests a model in which PrgY 
reduces endogenous pheromone production in donor cells by specifically binding 
to cCF10 and delivering it to one or more host proteins that degrade or modify 
the pheromone (Figure 12).  To test this model, purified His tag PrgY protein was 
used as the “bait” to capture and ‘pull down’ a protein-binding partner, the “prey” 
from OG1RF lysate that binds to PrgY.  His tag PrgY was mixed with an 
immobilized affinity ligand specific for the tag, thus creating a secondary affinity 
support to select other proteins that interact with PrgY.  The prey protein sample 
was then poured into the column where bait/prey interactions will cause the prey 
to be immobilized to the column.  DNA fragment encoding PrgY was amplified 
and cloned into the vector pET28b to obtain an N-terminal His-tag fusion 
expression plasmid.  The fusion protein PrgY was induced with isopropyl β-D-1-
thiogalactopyranoside (IPTG) and over expressed in Escherichia coli BL21(DE3) 
for purification.  Briefly, N-Y-His was bound to nickel column, and OG1RF cell 
lysate (the membrane faction which contain host proteases that may interact with 
PrgY) was added to the column and allowed for binding to N-Y.  A negative 
control consisting of a non-treated affinity column (minus bait, plus prey protein 
sample) was used to help identify false positives caused by nonspecific binding 
of proteins to the Nickel column.  Columns containing bound protein complexes 
were washed with high ionic strength buffers to eliminate any false positive result 
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due to nonspecific binding prior to elution with elution buffer.  The eluted fractions 
were assayed with Silver Stain (ThermoFisher Scientific) on 15% acrylamide 
SDS gel.  The N-terminus PrgY (N-Y) appeared to pull down some proteins from 
OG1RF cell lysate as indicated by the extra bands in elution fractions containing 
purified N-Y (Figure 13).  These extra bands only appeared in the N-Y/OG1RF 
elution fractions but not in the N-Y or OG1RF control fractions.  Four unique 
bands around 15-27 kDa and one blank spot (for control) were excised.  These 
bands were de-stained, digested with trypsin, and extracted for mass 
spectrometry analysis (see materials and methods).  Fragmentation spectra 
obtained from a trypsin digested protein sample were matched to a protein 
sequence database obtained from UNIPROT (http://www.uniprot.org) using 
MASCOT software (http://matrixscience.com).  In general, the trypsin digested 
peptides are mostly between 7 and 20 amino acids long, with an average of 11 
amino acids.  Scaffold software (http://www.proteomesoftware.com) was used to 
combine the most important data produced by MS with the identification process, 
and to distribute the results in an organized table.  Figure 14 contains the 
identified proteins, the accession number, predicted molecular weight, the 
probability, and the number of assigned spectra.  The filtering parameter was set 
at 95% probability with 1 peptide minimum.  Interestingly, bands #1,2, and 4 
contained sequences of cCF10 (not shown), suggesting that cCF10 may be 
bound tightly to N-Y and was pulled down with N-Y, which agreed with our 
binding kinetic data with slow off rate (Figure 10).  Gel bands #1 and #4 (Figure 
13) likely contain nonspecific degradation product of N-Y since N-Y has a  
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Figure 13.  Pull-down assay of N-Y and OG1RF membrane fractions.  The N-
Y-His was bound to nickel column, then OG1RF cell lysate (membrane faction) 
was added to the column and stored at 4°C for 1hr to allow binding.  The column 
was then washed with buffer to remove unbound materials and finally eluted into 
several fractions.  The eluted fractions were assayed with Silver Stain 
(ThermoFisher Scientific) on 15% acrylamide SDS gel.  Four unique bands 
around 15-27 kDa and one control band were excised, de-stained, digested with 
trypsin, and extracted for mass spectrometry analysis.    
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molecular weight of 34 kDa and that bands #1 and #4 have 3 and 2 spectra, 
respectively, that correspond to PrgY sequence (Figure 14).  GelE (20.7 kDa) 
and SprE (31.8 kDa) are host proteases that may be interacting with PrgY and 
lysozyme (14.7 kDA) or mutanolysin (23 kDa) are possible contaminants since 
they were used in OG1RF cell lysate preparation.  The numbers of assigned 
spectra give an idea of the confidence of the identification.  In general, a good 
identification should have at least 4 or more spectra that correspond to a 
particular protein [27].  With the exception of PrgY, all other proteins identified 
with Shotgun MS (Figure 14) had only 1 spectrum, with a 95% probability, 
suggesting that those proteins were most likely not present in the excised band 
samples.  
The full length PrgY was also tested with pull-down assays.  The full 
length PrgY appeared to pull down a ~35 kDa protein from OG1RF cell lysate, 
labeled “Band 7” (Figure 15).  The unique band was extracted for mass spec 
analysis.  Fragmentation spectra obtained from a trypsin digested protein sample 
were matched to a protein sequence database, as described above, to identify 
specific host proteins that may be interacting with PrgY.  Unfortunately, band #7 
corresponded to a degradation product of PrgY; lysozyme and trypsin were 
probably contamination from cell lysate and trypsin digest (Figure 16).  Keratin 
type I and type II are known common contaminants and could safely ignored.  
There is a possibility that the binding of PrgY and cCF10 changes PrgY’s 
conformation that is required prior to binding to a host protease and degrades 
cCF10.  Attempts were made to complex PrgY with synthetic cCF10 prior to  
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Figure 14. Shotgun MS analysis of unique gel bands of N-Y pull-down 
assay.  Five unique gel bands were excised, trypsin digested, and fragmentation 
spectra obtained from these bands were matched to a protein sequence 
database obtained from UNIPROT (http://www.uniprot.org) using MASCOT 
software (http://matrixscience.com).  Scaffold software 
(http://www.proteomesoftware.com) was used to combine the most important 
data produced by MS with the identification process, and to distribute the results 
in an organized table containing the identified proteins, the accession number, 
predicted molecular weight, the probability, and the number of assigned spectra.  
Filtering parameter was set at 95% probability with 1 peptide minimum.  Gel band 
#1 and band #4 likely contained nonspecific degradation products of N-Y.  In 
addition, band #1 and band #4 have 3 and 2 spectra, respectively, that 
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correspond to PrgY sequence, while all other proteins identified with Shotgun MS 
had only 1 spectrum, with a 95% probability, suggesting that those proteins were 
false positives and were most likely not present in the excised band samples.      
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 pull-down with OG1RF lysate, however, results (not shown) were indifferent.  It 
is interesting that PrgY, an important pheromone shut down protein, was very 
sensitive to degradation in the presence of OG1RF lysate.  Perhaps the “real” 
mechanism of PrgY is to soak up all of the excess cCF10 and complex 
eventually gets degraded by various host proteases to reduce pheromone 
activity.  This may explain why cCF10 binding to PrgY has a long off rate to allow 
PrgY to be saturated and degraded.   Alternatively, PrgY’s target protein may be 
located in the membrane and is not soluble under the experimental condition of 
the cell lysate preparation, or the complex between PrgY and host protease may 
have dissociated during the pull-down assay if the interactions were weak. 
Chemical cross-linking is another tool for detection and characterization of 
protein-protein interactions.  In general, individual protein members in a 
noncovalent complex assembly remain in close proximity which is within the 
reach of the two reactive groups of a cross-linker.  Thus cross-linking reactions 
have potential for linking two interacting proteins which exist in close proximity.  
Briefly, chemical cross-linking experiments was carried out by first linking the 
interacting proteins through covalent bonds using Disuccinimidyl glutarate (DSG), 
a water-insoluble homobifunctional crosslinker based on the amine-reactive N-
hydroxysuccinimide (NHS) ester group which was designed for membrane 
proteins. (see materials and methods).  The DSG has a spacer arm of 7.7 Å, and 
is cell membrane-soluble.  OG1RF pMSP3545 YSN culture was prepared in M9-
YE.  Cells were collected by centrifugation, crosslinked with DSG and assayed 
with Western blot.  A unique crosslinked band at ~95kDa was identified (Figure 
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Figure 15.  Pull-down assay of full-length PrgY and OG1RF membrane 
fractions.  N-Y-His or Full-length PrgY-His were bound to nickel column, OG1RF 
cell lysate (membrane faction) was added to the column and stored at 4oC for 1hr 
to allow binding.  The column was then washed with buffer to remove unbound 
materials and finally eluted into several fractions.  The eluted fractions were 
assayed with Silver Stain on 15% acrylamide SDS gel.  Unique bands were 
excised, de-stained, digested with trypsin, and extracted for mass spec analysis.    
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Figure 16. Shotgun MS analysis of unique gel bands of PrgY pull-down 
assay.  A unique gel band was excised, trypsin digested, and fragmentation 
spectra obtained from a unique gel band was matched to a protein sequence 
database, to identify specific host proteins that may be interacting with PrgY.  
Band #7 matched a degradation product of PrgY while lysozyme and trypsin 
were probably contamination from cell lysate and trypsin digest.  Keratin type I 
and type II are known common contaminants and thus were ignored.   
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17), however, when analyzed with mass spectrometry (as described above), 
PrgY was not identified in the band.  PrgY was probably cross-linked in such a 
way that mass spec could no longer identify the protein.  In theory, that unique 
band should contain PrgY along with its binding partners.  A possible binding 
partner is Eep, however, when performed the same crosslinking assay with a 
ΔEep strain, the same result was observed, suggesting that the observed 
crosslinked species was probably not related to Eep.  Attempts were made with 
immunoprecipitation to isolate PrgY from background proteins using PrgY 
antibody, however, there were too many background proteins, which caused 
mass spec column to clog.  When the sample was diluted, the background noise 
was high and the spectrum corresponding for PrgY was not identified.  
 
Comparative modeling of PrgY: a Structural Homolog of a Metalloprotease (TIKI) 
that modulates Wnt Signaling in Eukaryotes  
Results from pull-down assays and crosslinking assays were inconclusive, 
and suggested that N-Y and full-length PrgY were easily degraded in the 
presence of OG1RF cell lysate, under the experimental conditions.  Meanwhile, 
recent data suggested that PrgY shares significant homology to the eukaryotic 
metalloprotease TIKI that has been shown to cleave the amino terminus of 
mature Wnt proteins, thereby regulates the Wnt signaling.  Using a structural 
prediction algorithm, Bazan et al [28] indicated that PrgY and TIKI share key 
conserved residues in the metal-binding catalytic core as well as overall  
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Figure 17.  Crosslinking assay with E. faecalis OR1RF cell lysate over 
expressing PrgY.   Plasmid pMSP3545YSN expressing wild-type prgY in 
OG1RF was used in this crosslinking assay with Disuccinimidyl glutarate (DSG), 
a water-insoluble homobifunctional crosslinker based on the amine-reactive N-
hydroxysuccinimide (NHS) ester group.   Lanes 1 and 2 contain OG1RF 
(pMSP3545YSN) crosslinked with 1mM and 1.5mM of DSG respectively.  Lanes 
3 contains OG1RF (pMSP3545YSN) without DSG for positive control of PrgY 
expression.  Lane 4 contains OG1RF (pMSP3545) without DSG for negative 
control.   The dark band at ~48 kDa corresponds to PrgY monomer.  A unique 
crosslinked band at ~95kDa was identified.  
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secondary structure.  PrgY and TIKI share a common GX2H motif and a 
conserved glutamate.  Furthermore, 6 conserved amino acids have been 
predicted in the putative active site core of PrgY.  Although TIKI and PrgY 
proteins share limited sequence identity, their predicted secondary structures 
reveal a similar placement of β-strands and α-helices to anchor several potential 
conserved catalytic residues, consistent with a common evolutionary origin.  
Based on the structural similarity between PrgY and TIKI, we favor our original 
hypothesis in which PrgY reduces endogenous pheromone production in donor 
cells by specifically binding and degrading cCF10 as it is secreted across the 
cytoplasmic membrane (Figure 18).  To gain insights into the biochemical 
mechanism of PrgY, additional structure predictions were used to construct a 
three-dimentional template for PrgY based on distantly related proteins with 
known crystal structures.  Comparative modeling of PrgY was carried out with 
Phyre2 (see materials and methods) (Figure 19).  The N-terminus PrgY (residues 
1-241) is predicted to lie outside the membrane, and residues 125 to 241 of PrgY 
are required for specific regulation of cCF10 in vivo [9], shared significant 
homology to EreA/ChaN-like superfamily.  EreA is an erythromycin esterase, 
which inactivates macrolide antibiotic erythromycin through the hydrolysis of the 
macrolactone ring [32].  Furthermore, conserved residues E43, H46, E74, and 
H285 of EreA have been identified in the active site cleft and have been shown to 
play a role in catalysis [32].  ChaN (Campylobacter heme acquisition) is a 
putative lipoprotein thought to associate with the outer-membrane and has been  
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Figure 18.  Mechanism of action by TIKI and the proposed mechanism of 
action by PrgY.  TIKI is a metalloprotease that has been shown to cleave the 
amino terminus of mature Wnt proteins, thereby inactivating the Wnt ligand.  
Based on the structural similarity between PrgY and TIKI, we hypothesized that 
PrgY reduces endogenous pheromone production in donor cells by specifically 
binding and degrading cCF10 as it is secreted across the cytoplasmic 
membrane.  
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Figure 19.  Comparative modeling of PrgY was carried out with Phyre2.  
This figure describes the different parts of PrgY primary sequence homologous to 
other proteins with known structures.  The N-terminus PrgY (residues 1-241), is 
predicted to lie outside the membrane, and residues 125 to 241 of PrgY are 
required for specific regulation of cCF10 in vivo, shared significant homology to 
EreA/ChanN-like superfamily.  The C-terminus of PrgY is predicted to be in the 
membrane with four transmembrane domains, shared some homology to the 
membrane protein cytochrome b562.  Other alignments with lower confidence 
level are not shown. 
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shown to be important in heme acquisition in the Gram-negative Campylobacter 
jejuni [33].  The transmembrane helices of C-terminus of PrgY shares some  
homology to the membrane protein cytochrome b562.  These data suggests that 
PrgY may also contain four conserved residues in the putative active site similar 
to EreA: two His and two Glu.  The 3D structure model of PrgY was deduced by 
comparison to the available structures of EreA, ChaN, and cytochrome b562 
using Phyre2 and PyMOL (Figure 20).  PrgY point mutants that failed to reduce 
endogenous pheromone activity (Figure 4) are not very close in proximity in the 
primary sequence, however, they are in very close proximity in the predicted 3D 
structure of PrgY (Figure 20), strongly suggesting that they may be important in 
both binding to cCF10 and catalysis.  The N-terminus and C-terminus of PrgY 
are also predicted to be in very close proximity.  Bazan et al used MODELLER, 
followed by KoBaMIN structural refinement, to perform comparative modeling of 
the human TIKI1 active site [28] (Figure 21A).  Comparative modeling of PrgY 
active site was generated with Phyre2 and analyzed with PyMOL (Figure 21B, 
C).  The two proteins shared key conserved residues in the metal-binding 
catalytic core as well as overall secondary structure.  Furthermore, four key 
conserved residues in the putative active site of TIKI are H39, E66, E140, and 
H311 (Figure 21 A), map to the corresponding conserved residues in PrgY are 
H21, E45, D120, and H215 respectively (Figure 21B, C), implying a catalytic 
assembly for PrgY.  The combination of the inconclusive results from pull-down 
assays and crosslinking assays, and recent data suggested PrgY shares 
significant homology to the eukaryotic metalloprotease TIKI, a membrane bound   
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Figure 20.  3D structure model of PrgY.  Structure predictions were used to 
construct a three-dimentional template for PrgY based on distantly related 
proteins with known crystal structures including EreA, ChaN, and cytochrome 
b562.  PrgY point mutants that failed to reduce endogenous pheromone activity 
(Figure 4) are shown in “stick” form and are labeled.  These residues are not very 
close in proximity in the primary sequence, however, they are in very close 
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proximity in the predicted 3D structure of PrgY.  The N-terminus (dark blue) and 
C-terminus (red) of PrgY are also surprisingly in very close proximity.      
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Figure 21.  PrgY shares significant homology to the eukaryotic 
metalloprotease TIKI that regulates Wnt signaling.  Comparative modeling of 
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the human TIKI1 active site was previously carried out by MODELLER, followed 
by KoBaMIN structural refinement (A).  Comparative modeling of PrgY active site 
was carried out with Phyre2 and analyzed with PyMOL.  Four key conserved 
residues in the putative active site of TIKI are H39, E66, E140, and H311 (A), 
and the corresponding conserved residues in PrgY are H21, E45, D120, and 
H215 respectively (B).  (C) Full 3D structure model of PrgY with the 
corresponding conserved putative active site residues.    
  
70 
 
protease that has been shown to cleave the amino terminus of mature Wnt 
proteins, thereby inactivating them.  This led us to revisit our original model         
of PrgY in which PrgY was hypothesized to degrade cCF10 directly through its N-
terminal domain.   
 
PrgY cleaves cCF10 after the 2nd Leucine 
There are 19 human Wnt proteins and TIKI was shown to cleave 10 
human Wnt proteins [34].  Interestingly, the amino terminus of TIKI-cleavable 
Wnt are relatively hydrophobic, whereas the amino termini of non-cleavable Wnt 
are more polar with charged residues.  These observations suggest that the 
hydrophobicity of Wnt amino terminus is a major determinant of TIKI cleavage 
susceptibility.  This suggests that pheromones could be also susceptible to 
PrgY/TraB cleavage as pheromones are also very hydrophobic.  Furthermore, 
TIKI was shown to cleave Wnt3a after leucine [34], suggesting that PrgY may 
also cleave cCF10 after leucine.  Several possible degradation products of 
cCF10 were synthesized and analyzed with QTRAP 5500 to determine if it was 
able to reliably detect these small hydrophobic peptides.  Transition states and 
retention times for each of the synthetic peptides were collected (Table 4).  As 
expected, smaller fragments such as VFV, VTL, and LVTL had retention times of 
about 3 minutes and were eluted from the column around 30-40% ACN.  Full 
length peptide had a retention time of 8 minutes and was eluted form the C-18 
column at about 60 ACN.   
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Peptides Transition states Retention Time (min) 
VTL 332  201, 233 3.75 
VFV 364  247,265 4.60 
LVTL 445  332, 233, 213 5.94 
TLVFV 578  477 (not seen), 364, 461 8.42 
LVTLVFV 790  many transition states 11.24 
Table 4.  Mass spectrometry analysis of synthetic peptides.  50 ng of each 
synthetic peptides were added to M9-YE medium, purified with C-18 column, 
washed with 20% ACN with 0.1% TFA, and then eluted with 1.5 ml of 80% ACN 
with 0.1% TFA.  QTRAP 5500 was used to identify each peptides, transition 
states, and retention times.  
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Next, mass spectrometry was used to examine the PrgY-dependent 
cCF10 degradation products in culture supernatants from a strain expressing   
PrgY compared to control culture supernatant from an isogenic PrgY- derivative.  
A PrgY expression construct was previously made by fusing the prgY gene in-
frame with the first 3 codons of nisA gene in the nisin inducible promoter of 
pMSP3545S vector [14].  Plasmid pPCR4 was previously constructed to carry 
the prgQ Orf with an N-terminal peptide sequence derived from the iCF10 pre-
processed sequence and a pheromone cCF10 at the C-terminal end [9].  This 
strain produces about 400 ng/ml of cCF10, about 100-fold higher than cCF10 
produced from the chromosomal ccfA allele in wild type strains.  Culture 
supernatants were collected from two isogenic strains, one carrying both the 
PrgY and cCF10 expression plasmids, while the second strain only carried the 
cCF10 expression construct. We expected to find significant amount of cCF10 in 
both culture supernatants, but we anticipated that the strain carrying both 
expression plasmids would produce less cCF10, and possibly unique cCF10 
fragments resulting from PrgY cleavage. Culture supernatants were purified with 
a C-18 column.  Based on the transition states and the retention times from 
synthetic peptides (Table 4), QTRAP 5500 was used to examine PrgY-
dependent cCF10 degradation products in donor culture supernatants. Peptide 
LVTL was identified only in culture supernatant from the strain expressing PrgY 
(Table 5), suggesting that PrgY cleaves cCF10 after the second leucine.  
Interestingly, VFV was identified in donor culture supernatant expressing PrgY, in 
control culture supernatant lacking PrgY, in control medium M9-YE +  
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 JRC105 pPCR4 
(pMSP3545Y) 
JRC105 pPCR4 
(pMSP3545S) 
M9-YE + 
LVTLVFV 
M9-YE 
Peptides 
Identified 
LVTL 
VFV 
TLVFV 
LVTLVFV 
VFV 
TLVFV 
LVTLVFV 
VFV  
LVTLVFV 
VFV 
Table 5.  Mass spectrometry analysis of culture supernatants.  Mass 
spectrometry was used to examine the PrgY-dependent cCF10 degradation 
products in donor culture supernatant expressing PrgY (JRC105 pPCR4 
(pMSP3545Y)) compare to control culture supernatant lacking PrgY (JRC105 
pPCR4 (pMSP3545S)).  Both strains lack gelE and sprE, the two major 
proteases in OG1RF.  Peptide LVTL (bold) was uniquely identified in donor 
culture supernatant expressing PrgY.  
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synthetic LVTLVFV, and in M9-YE control medium.  Both donor culture 
supernatant expressing PrgY and control supernatant lacking PrgY contained 
TLVFV, suggesting that a host exopeptidase in both culture supernatants may 
have cleaved two residues at the N-terminus of cCF10 (Table 5).  
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DISCUSSION 
 Based on previous genetic data [9], it was clear that cCF10 is specifically 
controlled by PrgY, however, a direct interaction between PrgY and cCF10 has 
not been demonstrated.  Reduction of endogenous pheromone by PrgY pCF10-
containing donor cells is critical for prevention of self-induction. PrgY was shown 
by genetic studies to target the mature cCF10 rather than other part of the signal 
peptide that it is processed from.  It was also unknown whether PrgY directly 
degrades cCF10 or mediates its function indirectly though other proteins.   
I have demonstrated that N-Y reduces amount of pheromone flow-thru in 
pull-down assays, confirming the direct binding between cCF10 and N-Y in vitro 
(Figure 9).  The peptide cPD1 partially blocked binding of N-Y and cCF10 (Figure 
9C).  Surface Plasmon Resonance (SPR) spectroscopy was used to quantify the 
binding interaction between PrgY and cCF10.  The data suggests that cCF10 
binds to N-Y very slowly (low on rate), and it also falls off very slowly (slow off 
rate) (Figure 10A).  This result is in agreement with my biochemical studies which 
required incubation of N-Y and synthetic pheromone for 1 hr prior to adding 
responder cells for activity (Table 3).  The slow on rate suggests that in its natural 
environment, PrgY anchors in the cell membrane, probably in close proximity to 
Eep and in a precise orientation, such that it readily captures mature cCF10 
immediately upon release from the membrane and before reimport by PrgZ.  The 
slow on rate was most likely due to the limitation of this in vitro assay as it lacks 
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the transmembrane domain and consequently N-Y was unable to effectively 
capture cCF10. 
The three best studied pheromone-inducible conjugative plasmids are 
pAD1, pPD1, and pCF10 [13].  These plasmids share a similar mechanism of 
regulation.  There is partial cross reactivity between pPD1 and pCF10 system, 
however, there is no cross reactivity between the pAD1 and pCF10 systems.  
The pheromone protective activity of N-Y was specific and not observed with the 
pAD1-inducing cAD1 pheromone [35] (Table 3B).  In addition, this activity was 
not observed with a L4I variant of cCF10 that is insensitive to PrgY inhibition in 
vivo [9].  Furthermore, the corresponding N-terminal fragments of two PrgY 
variants that failed to reduce pheromone production in vivo did not show this 
binding activity (Table 3C).  Furthermore, the corresponding N-terminal 
fragments of two PrgY variants that failed to reduce pheromone production in 
vivo did not show this binding activity (Table 3C).  This suggests that the 
extracellular N-terminal domain of PrgY has a specific cCF10 binding activity.    
The results of this work revealed that N-Y directly interacts with cCF10.  
N-Y appeared to interact with cCF0 at the nM range and thus a long injection 
time was needed to increase the signal.  Since the signal strength is directly 
proportional to the molecular weight, it might be possible to immobilize the 
peptide to the sensor chip and flow N-Y across; however, there may be some 
potential issues associated with immobilization of the small peptide, and perhaps 
a linker would be needed.  Results from assays using various combinations of N-
Y and peptide variants (Figure 9, 10) confirmed the binding specificity and 
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complemented subsequent in vivo and in vitro assays.  The SPR setup 
conditions and fusion protein used in this study may be useful tools for 
subsequent kinetic analysis of proteins PrgY, PrgX, and PrgZ for cCF10 and 
iCF10 peptides.  These three proteins are encoded on the same plasmid 
involved in conjugation and are responsible for the spread of antibiotic resistance 
genes.  They serve different functions in regulating conjugation and yet all three 
proteins interact with the same seven amino acid peptide.  Understanding how 
these three proteins evolved and how they interact with the peptides allows us to 
potentially design peptide mimetics that bind to these specific proteins and 
“freeze” the peptide/protein complex to a non-functional state in order to reduce 
or eliminate conjugation and the spread of antibiotic genes.  
Results from the pull-down assay and SPR provided great binding kinetic 
data between N-Y and cCF10, however, no degradation was observed.  These 
results suggest that the C-terminal domain of PrgY may be required to anchor 
PrgY in the membrane with a specific conformation that is needed for optimal 
pheromone-degrading enzymatic activity, but not for specific binding.  For this 
reason, the absence of the C-terminal domain of PrgY in these in vitro assay only 
resulted in binding but not degradation.  Initial attempts to use full length PrgY in 
this type of assay were unsuccessful due to immediate precipitation of PrgY 
during the assay.  However, PrgY was later successfully purified with reasonable 
efficiency and stability and micro-titer assays were used to detect pheromone 
activity in the presence of purified full-length PrgY.  Unfortunately, results with 
purified full-length PrgY were very similar to those obtained with N-Y.  This 
78 
 
reinforces the idea that the transmembrane portion of PrgY is not involved in 
catalytic activity but is likely required to anchor PrgY in the membrane for optimal 
pheromone-degrading enzymatic activity.   
The lack of peptidase activity observed with purified proteins may be 
related to folding problems in solution or its interacting partner was missing when 
it was purified.  This led us to hypothesize that PrgY does not directly degrade 
pheromone as we previously thought but it may interact with a cell-associated 
protease or peptidase for degradation (Figure 11).  We began searching for a 
host protease that may interacts with PrgY using pull-down assays and 
crosslinking assays.  Full length PrgY and N-Y appeared to pull down several 
unique proteins from OG1RF cell lysate (Figure 13, 15).  Fragmentation spectra 
obtained from a trypsin digested protein sample were matched to a protein 
sequence database to identify specific host proteins that may be interacting with 
PrgY.  Unfortunately, these bands corresponded to a degradation product of 
PrgY or contaminants from cell lysate and trypsin digest (Figure 16).  In the case 
of N-Y, gel band #1 and band #4 likely contained nonspecific degradation 
products of N-Y since they had lower molecular weights than N-Y at 34 kDa 
(Figure 13, 14).  In addition, band #1 and band #4 had 3 and 2 spectra, 
respectively, that corresponded to PrgY segments, while all other proteins 
identified with Shotgun MS had only 1 spectrum, with a 95% probability, 
suggesting that those proteins were false positives (Figure 14).  The combination 
of these negative results and the new structural data on TIKI triggered a change 
in direction and led us to re-examine the protease activity of PrgY. 
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The striking similarity between the 3D structure of TIKI and the predicted 
structure of PrgY suggested that PrgY may have similar activity.  The amino 
termini of TIKI-cleavable Wnt proteins are relatively hydrophobic compared to the 
amino termini of non-cleavable Wnt.  Similarly, pheromones are also very 
hydrophobic, suggesting that pheromones could be also susceptible to 
PrgY/TraB cleavage.  Mass spectrometer QTRAP 5500 was used to examine 
whether PrgY-dependent cCF10 degradation products can be detected in donor 
culture supernatants.  Peptide LVTL was uniquely identified in donor culture 
supernatants expressing PrgY (Table 5).  This suggests that PrgY cleaved 
cCF10 after the second leucine, and released the degraded peptide fragments 
LVTL and VFV that do not have any pheromone activity.  TIKI was also shown to 
cleave Wnt3a after leucine [34].  This is an important piece of information as it 
suggests that PrgY is in fact a protease that degrades pheromone cCF10 rather 
than simply blocking the mature cCF10 from releasing into the cell medium.  
Peptide VFV was identified in all samples suggesting that VFV was most likely 
came from the casamino acids that was used to formulate M9-YE.  Although both 
strains lack gelE and sprE, the two major proteases in OG1RF, there are likely 
other host exopeptidases in the culture supernatant that may have cleaved two 
residues at the N-terminus of cCF10, resulting in peptide fragment TLVFV in 
culture supernatants (Table 5).    
 We also examined the possibility of the degradation products of cCF10 for 
inhibitory activity similar to iCF10, and further controls endogenous pheromone.  
Arpan Bandyopadhyay, a graduate student in chemical engineering who works 
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on the pheromone project in collaboration with our lab, examined both the VFV 
and LVTL fragments of cCF10, and found that they do not have any inhibitory 
activity or pheromone activity.  Therefore all of the functional activity of PrgY 
relates to reduction of endogenous pheromone and not to generation of an 
inhibitory peptide. 
  Proteases likely arose at the earliest stages of protein evolution as simple 
destructive enzymes essential for protein catabolism and the generation of amino 
acids.  At a certain point, E. faecalis OG1RF (pCF10) acquired genes that coded 
for an early version of PrgY.  This early version of PrgY likely did not contain the 
specificity domain for cCF10, and that the specific binding affinity to cCF10 was 
later acquired to enhance the regulation of the pheromone system and to 
minimize fitness cost.  PrgY likely did not evolve from a single evolutionary line 
from one common ancestor.  Interestingly, PrgY does not contain any structural 
motif that resembles known metalloprotease.  Then at some point, metazoans, 
including humans and mammals, acquired the catalytic domain of PrgY to serve 
as a nonspecific enzyme necessary for protein catabolism, particularly degrading 
hydrophobic peptides.  It is likely that the selective pressure and the extensive 
combinatorial activity served as a driving force in the protease transition from 
nonspecific enzymes such as early versions of PrgY and TIKI, to highly selective 
proteases responsible for critical proteolytic processing.  The nonspecific 
degradative function of the early version of TIKI evolved and eventually links its 
catalytic domain to a specialized domain that provide substrate specificity, 
including the specificity region that recognizes Wnt proteins.  It is interesting to 
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note that all known bacterial sex pheromones, which are putative PrgY/TraB 
substrates, are hydrophobic short peptides [10].  Similarly, TIKI-cleavable Wnt 
are relatively hydrophobic, whereas the amino termini of non-cleavable Wnt often 
contain more charged and polar residues [34].  These observations suggest that 
the hydrophobicity of the Wnt amino terminus is a major determinant of TIKI 
cleavage susceptibility.  This allows TIKI to cleave at least 10 of the 19 Wnt 
proteins found in humans [34].  In contrast, PrgY is highly specific to cCF10 and 
that a L4I peptide variant of cCF10 abolished PrgY ability to reduce pheromone 
activity in donor cells [9].  These data suggest that TIKI’s specificity region did not 
evolve from PrgY.  Changes to PrgY occurred mostly at the sequence level 
leaving the structures and the catalytic domain rather conserved in TIKI.  This 
can be used to explain the presence of homology between PrgY and TIKI, which 
share similar structures but have adapted to perform different functions.  It would 
be interesting to clone the specificity region of prgY into TIKI and determine if 
TIKI could cleave cCF10, or vice versa.  Based on previous experiments 
structural analysis, wild-type PrgY is unlikely to be able to cleave Wnt proteins as 
PrgY specificity region is quite specific to cCF10.  Furthermore, PrgY may lack a 
cofactor that plays a role in coordinating amino acids in the active site of TIKI.  
Moreover, it would be interesting to consider how PrgY expression impacts on 
the host fitness, virulence, and the expression of aggregation substance, Asc10, 
as Asc10 has been shown to increase colonization and virulence by promoting 
biofilm formation and attachment to host tissues, and by increasing resistance to 
phagocytic killing [20-22].   
82 
 
TIKI is known to cleave Wnt, and the cleavage is enhanced by Co2+ or 
Mn2+, but is inhibited by Ni2+, Cu2+, or Zn2+ in vitro.  Unfortunately, I have been 
purifying PrgY with Ni2+ column which may inhibits its activity.  For this reason, 
PrgY was later purified Cobalt column (ThermoFisher Scientific).  The 
pheromone activity was assayed in the presence and absence of PrgY, purified 
with Cobalt column.  Unfortunately, there was no significant difference in 
pheromone activity in the presence of PrgY purified with Cobalt column versus 
Nickel column (data not shown).  Furthermore, PrgY was incubated with Co2+, 
Mn2+, Ni2+, Cu2+, or Zn2+ in vitro and assayed for its activity, however, no 
significant change in pheromone activity in the presence of these metal ion 
cofactors.  It is very likely that these cofactors were readily available in M9-YE.  
Additional experiments, particular in a chemically defined medium, are needed to 
elucidate the specific metal ion that is required and possibly enhance PrgY 
activity.        
At the beginning of the post-genomics era, an enormous amount of 
information is available about the composition and organization of proteolytic 
systems in many living organisms. These broad genomic views have revealed 
that the protease landscape is vast and quite unexplored.  For example, the 
recently identified TIKI represents a new metalloprotease family that is 
dependent on Co2+ or Mn2+ but lacks known metalloprotease motifs.  The TIKI 
fold is considered a new addition to the metalloprotease pantheon.  Likewise, 
structural modeling of PrgY using Phyre2 gives a model with a 96% confidence 
level over most of the extracellular domain (Figure 19), yet the model does not 
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contain any structural motif that resembles known metalloprotease.  PrgY 
represents a new metalloprotease family similar to TIKI.  The size of the different 
degradomes will continue to grow in the near future, as new enzymes with 
unique structural designs and catalytic mechanisms are identified and 
characterized.  These protease studies will contribute to the elucidation of 
genetic diseases caused by mutations in protease loci and gene polymorphisms 
associated with an increased susceptibility to certain diseases.  A deeper 
understanding of these interactions would open the door to the modeling of 
three-dimensional structures that may help us to design drugs targeting important 
interactions in various types of cancer and other diseases.    
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